Jul 24
Current report
8-K
Events of Jul 19
Delisting notice or listing transfer
CNSP · CNS Pharmaceuticals, Inc. · Documents
Market Cap
$5.29M
Shares
1.46M
Volume · Nov 12
2870
Avg daily vol (3M)
9663
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2024
Jul 19
Registration statement
S-1/A
Registration statement
Jul 12
Current report
8-K/A
Events of Jul 5
Other events
Jul 12
Registration statement
S-1
Registration statement
Jul 9
Current report
8-K
Events of Jul 5
Other events
Jul 3
Current report
8-K
Entered into a material agreement, Unregistered sale of equity, Other events
Jun 26
Current report
8-K
Entered into a material agreement, Unregistered sale of equity, Other events
Jun 20
Current report
8-K/A
Events of Jun 14
Current report
Jun 14
Current report
8-K
Entered into a material agreement, Unregistered sale of equity, Other events
Jun 10
Registration statement
S-1
Registration statement
Jun 5
Current report
8-K
Events of Jun 3
Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Other events
May 16
Current report
8-K
Financial results
May 15
Quarterly report
10-Q
FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Net loss $3.54M
Diluted EPS -$0.41
May 9
Registration statement
S-3
Registration statement
May 7
Current report
8-K
Events of May 6
Other events
May 3
Current report
8-K
Events of Apr 30
Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results
Apr 15
Current report
8-K
Events of Apr 9
Regulation FD disclosure
Apr 10
Proxy statement
DEF 14A
Meeting Apr 30, 2024
Proxy statement
Apr 1
Current report
8-K
Financial results
Apr 1
Annual report
10-K
FY2023, ended Dec 31
Annual report for FY2023
Net loss $18.85M
Diluted EPS -$5.00
Mar 28
Proxy statement
PRE 14A
Meeting Apr 30, 2024
Proxy statement
Feb 27
Current report
8-K
Events of Feb 21
Delisting notice or listing transfer, Director or officer change, or executive pay
Feb 21
Current report
8-K
Events of Feb 14
Delisting notice or listing transfer
Feb 2
Current report
8-K
Events of Jan 29
Entered into a material agreement, Director or officer change, or executive pay
Jan 23
Current report
8-K
Events of Jan 17
Director or officer change, or executive pay
Jan 22
Registration statement
S-1/A
Registration statement
Jan 10
Registration statement
S-1/A
Registration statement
2023
Dec 21
Current report
8-K
Regulation FD disclosure
Dec 18
Current report
8-K
Regulation FD disclosure, Other events
Dec 8
Registration statement
S-1
Registration statement
Nov 20
Registration statement
S-3
Registration statement
Nov 15
Current report
8-K
Financial results
Nov 14
Quarterly report
10-Q
FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Net loss $4.52M
Diluted EPS -$1.08
Oct 18
Current report
8-K
Regulation FD disclosure
Oct 17
Current report
8-K
Events of Oct 16
Entered into a material agreement, Unregistered sale of equity
Sep 19
Current report
8-K
Events of Sep 14
Shareholder vote results
Aug 18
Current report
8-K
Events of Aug 17
Delisting notice or listing transfer
Aug 15
Current report
8-K
Events of Aug 11
Charter or bylaw amendment, or fiscal year change
Aug 14
Proxy statement
DEF 14A
Meeting Sep 14, 2023
Proxy statement
Aug 14
Current report
8-K
Financial results
Aug 14
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Net loss $4.02M
Diluted EPS -$1.04
May 15
Current report
8-K
Financial results
May 15
Quarterly report
10-Q
FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Net loss $4.93M
Diluted EPS -$2.59
May 8
Current report
8-K
Events of May 3
Director or officer change, or executive pay, Regulation FD disclosure
May 1
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2022
Mar 31
Annual report
10-K
FY2022, ended Dec 31
Annual report for FY2022
Net loss $15.27M
Diluted EPS -$11.22
Jan 3
Current report
8-K
Events of Dec 30
Director or officer change, or executive pay, Regulation FD disclosure
2022
Dec 14
Current report
8-K
Events of Dec 13
Other events
Dec 1
Current report
8-K
Events of Nov 30
Entered into a material agreement, Other events
Nov 28
Showing 51–100 of 170 documents